<DOC>
	<DOCNO>NCT01560767</DOCNO>
	<brief_summary>Peri-articular knee infiltration Levobupivicaine 150mg , Morphine 10mg Ketorolac 30mg reduces postoperative pain follow primary total knee replacement compare current standard treatment femoral nerve blockade .</brief_summary>
	<brief_title>Perioperative Analgesia Knee Arthroplasty ( PAKA )</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>All patient undergo elective primary unilateral total knee arthroplasty ( TKA ) care orthopaedic consultant University Hospitals Coventry Warwickshire NHS trust potentially eligible trial . Those sufficient cognitive impairment would unable complete questionnaire ( cognitive impairment ) . Those patient lack capacity Mental Capacity Act 2005 Those patient preoperative history neurological abnormality ipsilateral leg e.g . history stroke , neurogenic pain previous nerve injury . Those patient spinal anaesthesia . Those patient specific contraindication analgesic agent use : Morphine : Hypersensitivity reaction Ketorolac : Active previous peptic ulcer . History upper gastrointestinal bleeding perforation , relate previous NSAID therapy . Haemorrhagic diatheses , include coagulation disorder Hypersensitivity ketorolac trometamol NSAIDs Moderate severe renal impairment ( serum creatinine &gt; 160 micromol/l ) Levobupivicaine : Levobupivacaine solution contraindicate patient know hypersensitivity levobupivacaine , local anaesthetic amide type excipients Uncontrolled angina 2nd/ 3rd degree heart block</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Pain relief</keyword>
	<keyword>Arthroplasty</keyword>
	<keyword>periarticular knee infiltration</keyword>
</DOC>